Project data

• IATI IdentifierXM-DAC-6-4-012607-01-1
• AID012607/01/1
• CRS Activity identifier2022000365
• Planned start 2022/10/01
• Planned End 2024/09/30
• Actual start -
• Actual end -
• Bi/Multilateral Bilateral
• Status Implementation
• Tied status Untied

Sectors

• 11110 - Education policy and administrative management 100.0%

Policy markers

• Gender Equality significant objective
• Disaster Risk Reduction(DRR) not targeted
• Disability not targeted
• Nutrition significant objective
• Aid to Environment not targeted
• Participatory Development/Good Governance principal objective
• Trade Development not targeted
• Aid Targeting the Objectives of the Convention on Biological Diversity not targeted
• Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation not targeted
• Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation not targeted
• Aid Targeting the Objectives of the Convention to Combat Desertification not targeted
• Reproductive, Maternal, Newborn and Child Health (RMNCH) significant objective

SDGs

• 3.2 - By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under-5 mortality to at least as low as 25 per 1,000 live births
• 3.3 - By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases
• 3.4 - By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being
• 3.b - Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all